Dillmon Melissa S, Saag Michael S, Hamza Sate H, Adler Brian K, Marques Marisa B
Department of Medicine, University of Alabama School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35249, USA.
AIDS Res Hum Retroviruses. 2005 Sep;21(9):753-6. doi: 10.1089/aid.2005.21.753.
Recent reports indicate that patients infected with HIV are at increased risk for the development of thrombosis. Among other possibilities, an acquired deficiency of protein S (PS), one of the plasma's natural anticoagulants, might explain this tendency. PS deficiency can be classified in three types depending on the levels of total and free protein (antigenic assays) as well as anticoagulant activity (functional assay). Although the prevalence of inherited PS deficiency is not known because of its rarity, several conditions can lead to acquired forms of the disease. We report two AIDS patients with coexistent type III PS deficiency and thrombosis. Our first patient presented with bilateral chronic leg ulcers and a skin biopsy revealed dermal microthromboses. On laboratory evaluation he had PS deficiency and was started on anticoagulation, but was lost to follow-up. The second patient presented with hepatic vein thrombosis (Budd-Chiari syndrome) and was also PS deficient. On long-term anticoagulation, she experienced resolution of the thrombosis. Neither patient had prior personal or family history of venous thrombosis, nor acquired risk factors such as immobility, acute infection, recent surgery, or hormonal therapy. The literature contains a few reports of skin ulcers and Budd-Chiari syndrome associated with PS deficiency, although none in AIDS patients. While a larger number of studies describe an association between PS deficiency and HIV infection, the causal effect of this deficiency on the thrombophilic tendency in AIDS has not been established. We propose that awareness of the increased risk for thrombosis in HIV infection is important to the understanding of disease pathophysiology and management of these patients.
最近的报告表明,感染艾滋病毒的患者发生血栓形成的风险增加。在其他可能性中,血浆天然抗凝剂之一的蛋白S(PS)后天缺乏可能解释了这种倾向。PS缺乏可根据总蛋白和游离蛋白水平(抗原检测)以及抗凝活性(功能检测)分为三种类型。由于遗传性PS缺乏症罕见,其患病率尚不清楚,但几种情况可导致该疾病的后天形式。我们报告了两名同时患有III型PS缺乏症和血栓形成的艾滋病患者。我们的首例患者出现双侧慢性腿部溃疡,皮肤活检显示真皮微血栓形成。实验室评估显示他存在PS缺乏,并开始接受抗凝治疗,但失访。第二名患者出现肝静脉血栓形成(布加综合征),也存在PS缺乏。经过长期抗凝治疗,她的血栓形成得到缓解。两名患者既往均无个人或家族静脉血栓形成病史,也没有诸如活动减少、急性感染、近期手术或激素治疗等后天危险因素。文献中有一些关于与PS缺乏相关的皮肤溃疡和布加综合征的报告,尽管艾滋病患者中尚无此类报告。虽然大量研究描述了PS缺乏与艾滋病毒感染之间的关联,但这种缺乏对艾滋病患者血栓形成倾向的因果作用尚未确立。我们认为,认识到艾滋病毒感染中血栓形成风险增加对于理解这些患者的疾病病理生理学和管理至关重要。